How Long Does Low Dose Naltrexone Take to Work?
If you recently started Low Dose Naltrexone, or are considering it, you probably have one important question:
How long will it take before I know whether LDN is working?
The most accurate answer is that there is no universal LDN timeline. Some people may notice changes earlier, while others may require a longer clinician directed evaluation. Some patients may not experience meaningful improvement at all.
Clinical studies have commonly evaluated Low Dose Naltrexone over several weeks, including treatment periods of approximately 8 to 12 weeks. That does not mean every patient should expect results within a specific number of days or continue treatment for a predetermined period without follow up.
The underlying condition, treatment goals, other medications, individual tolerability, and method used to measure improvement all matter.
A Quick Review: What Is Low Dose Naltrexone?
Naltrexone is a prescription opioid antagonist. It binds to opioid receptors and blocks the effects of opioid medications.
FDA approved oral naltrexone is indicated as part of treatment for alcohol dependence and for blocking the effects of externally administered opioids. When naltrexone is prescribed at a lower dose for fibromyalgia, persistent pain, or other chronic symptoms, that use is considered off label.
Low Dose Naltrexone is commonly shortened to LDN.
If you are just beginning your research, read our first guide:
What Is Low Dose Naltrexone? Uses, Evidence, and Safety
If you are trying to determine whether you may be evaluated for treatment, continue with:
Low Dose Naltrexone for Chronic Pain: Could LDN Be Right for You?
Why Is There No Single LDN Response Timeline?
LDN is being studied across several different conditions. These conditions do not share the same symptoms, causes, clinical course, or methods for measuring improvement.
A person with fibromyalgia may be monitoring pain, sleep, fatigue, and daily function. Someone with another persistent pain condition may be focused on symptom flares or the ability to complete normal activities.
The apparent response timeline may be affected by:
- The condition being evaluated
- Baseline symptom severity
- The patient’s individual treatment plan
- Other medications and therapies
- Consistency of use
- Side effects or tolerability
- The outcome being measured
- The timing of clinical follow up
This is why a responsible treatment plan begins with measurable goals rather than a promise that a patient will “feel better” by a certain date.
What Do LDN Studies Tell Us About Timing?
Fibromyalgia studies
Fibromyalgia has received more LDN research attention than many other off label applications.
A 2013 randomized crossover study involving 31 women with fibromyalgia evaluated Low Dose Naltrexone during a 12 week active treatment phase. The study reported a greater reduction in baseline pain during LDN treatment than during placebo treatment, but the researchers described the evidence as preliminary. Review the study on PubMed.
A larger randomized trial published in 2024 also evaluated LDN for 12 weeks. That study did not find that 6 mg of naltrexone was superior to placebo for reducing pain in women with fibromyalgia. Review the 2024 trial.
More recent reviews and meta analyses have reached somewhat different conclusions regarding potential pain improvement. A 2025 systematic review and meta analysis reported a pain benefit compared with placebo, but the total evidence remains limited by relatively small trials, different methods, and variations in treatment design.
The practical takeaway is important:
Study duration should not be confused with a guaranteed response timeline.
A 12 week clinical trial tells us how long researchers observed participants. It does not prove that every patient should notice improvement by week 12 or that treatment should automatically continue for that length of time.
Chronic pain research
Reviews of LDN for chronic pain describe promising results in some populations, but the evidence remains inconsistent.
A 2025 systematic review concluded that LDN performed better than placebo in fibromyalgia pain management and similarly to certain active controls in broader chronic pain research. Review the systematic review.
However, a 2024 study involving patients with different chronic pain conditions did not find meaningful improvement in pain or quality of life. Review the conflicting study.
This mixed evidence is another reason not to publish a universal timeline. The type of pain condition and the individual patient may influence whether a benefit is observed at all.
What Might Improvement Look Like?
Patients often expect treatment to produce a dramatic moment when they suddenly feel different. Improvement in a chronic condition may be more gradual or subtle.
Depending on the treatment goal, possible changes worth discussing with a clinician may include:
- Lower average pain intensity
- Fewer severe symptom flares
- Better sleep quality
- Less morning stiffness
- Improved ability to walk or exercise
- Greater participation in household activities
- Improved work function
- Reduced fatigue
- More manageable symptoms
- Improved overall quality of life
These changes do not prove that LDN caused the improvement. Symptoms can change because of sleep, activity, stress, diet, other treatments, and the natural course of a condition.
Tracking symptoms consistently gives the clinician more useful information than relying on memory alone.
How Do You Know if LDN Is Working?
Before treatment begins, identify the two or three outcomes that matter most.
For example:
A simple weekly record may include:
- Average pain level
- Sleep quality
- Fatigue
- Number of symptom flares
- Daily activity
- New or worsening symptoms
- Missed doses
- Changes in other medications
The goal is not to produce perfect data. It is to create a clearer discussion with the prescriber.
What Should You Expect When Starting LDN?
A clinician or pharmacist should explain:
- The prescribed strength and directions
- The symptom or condition being targeted
- Potential medication conflicts
- Possible side effects
- When follow up should occur
- When to contact the clinical team
- What would justify continuing, changing, or stopping treatment
Patients should take the medication exactly as prescribed. They should not increase, decrease, divide, or change the timing of a dose unless directed by the treating clinician.
There is no single internet protocol that is appropriate for every patient.
Are Early Side Effects a Sign That LDN Is Working?
No. A side effect is not proof that a medication is working.
Some online sources describe headaches, fatigue, sleep disruption, or worsening symptoms as evidence that the body is adjusting or “detoxing.” These explanations should not replace a clinical evaluation.
Reported effects associated with naltrexone can include:
- Nausea
- Headache
- Dizziness
- Fatigue
- Abdominal discomfort
- Difficulty sleeping
- Sleepiness
- Nervousness
- Vivid dreams
The FDA approved prescribing information for standard dose naltrexone includes adverse reaction information, but the frequency and pattern observed at standard doses cannot automatically be applied to every compounded LDN prescription. Review the naltrexone prescribing information through DailyMed.
New, persistent, severe, or worsening symptoms should be reported to the prescriber. Patients should not assume that feeling worse is a required step toward improvement.
What if LDN Is Affecting Sleep?
Sleep changes are among the commonly discussed concerns surrounding LDN. Some patients report difficulty sleeping or vivid dreams, while others may be taking LDN partly because sleep disruption is associated with their underlying condition.
If sleep changes occur, track:
- Time the medication was taken
- Time required to fall asleep
- Nighttime awakenings
- Vivid or disturbing dreams
- Total sleep time
- Daytime fatigue
- Other recent medication or lifestyle changes
Share the information with the prescriber or pharmacist. Do not independently change the dose or administration schedule based solely on an online recommendation.
When Should You Contact Your Provider?
Contact the treating provider when:
- Side effects are persistent or difficult to tolerate
- Symptoms become noticeably worse
- Sleep disruption affects normal functioning
- New mood symptoms appear
- Another clinician prescribes a new medication
- Surgery or a procedure is planned
- Emergency pain treatment may be needed
- There is no clear follow up plan
- You are unsure whether treatment is helping
Seek prompt medical attention for concerning symptoms such as yellowing of the skin or eyes, dark urine, persistent abdominal pain, severe vomiting, confusion, or signs of an allergic reaction.
The Most Important Safety Reminder: LDN and Opioids
Naltrexone blocks opioid receptors.
FDA approved labeling states that naltrexone is contraindicated in patients receiving opioid analgesics, patients with current physiologic opioid dependence, and patients experiencing acute opioid withdrawal.
Starting naltrexone too soon after opioid exposure can precipitate sudden withdrawal, which may be severe.
Patients must disclose:
- Prescription opioid pain medications
- Tramadol
- Buprenorphine
- Methadone
- Opioid containing cough medicines
- Opioid containing diarrhea medicines
- Any recent nonprescribed opioid use
Patients should not stop an opioid or determine an opioid free interval without medical supervision.
Naltrexone may also interfere with opioid pain treatment during an emergency, injury, or surgical procedure. Make sure every treating healthcare professional knows that you take LDN.
What if LDN Does Not Appear to Be Working?
Lack of improvement does not automatically mean the dose should be increased.
The clinician may need to consider:
- Whether the original diagnosis remains accurate
- Whether the treatment goal was realistic
- Whether enough consistent information has been collected
- Whether other medications or conditions are affecting symptoms
- Whether side effects outweigh any benefit
- Whether another treatment approach is more appropriate
A medication should not continue indefinitely simply because improvement might eventually occur.
The patient and prescriber should agree on a reassessment point and determine whether there is enough benefit to justify continued treatment.
Why Pharmacy Consistency Matters
LDN is often compounded because the commercially available 50 mg naltrexone tablet may not provide the patient specific strength or dosage form selected by the prescriber.
Working with one pharmacy can help maintain continuity involving:
- The prescribed formulation
- Administration instructions
- Refill timing
- Medication records
- Pharmacist counseling
- Communication with the prescriber
The completed compounded medication is not FDA approved. FDA does not review compounded preparations for safety, effectiveness, or quality before marketing. Compounding may serve an important medical need when an FDA approved medication does not meet an individual patient’s needs. Read the FDA’s compounded medication guidance.
The Bottom Line
There is no guaranteed answer to how long Low Dose Naltrexone takes to work.
Studies have evaluated LDN over periods such as 8 to 12 weeks, but a research timeline is not a promise of individual results. Some patients may notice changes earlier, some later, and others may not experience meaningful benefit.
A better question is:
What specific change are we trying to achieve, how will we measure it, and when will we reassess the plan?
That conversation turns a vague waiting period into an informed, clinician directed treatment evaluation.
Explore LDN With Scripx Pharmacy
Scripx Pharmacy supports patient specific compounded prescriptions, medication education, and pharmacist guided care.
If you are interested in LDN, complete the appropriate clinical evaluation. A licensed provider will review your medical history, current medications, opioid exposure, symptoms, treatment goals, and state eligibility before determining whether a prescription is appropriate.
Start your LDN consultation: CONSULT PAGE HERE
Completing an evaluation does not guarantee treatment or a prescription. Telehealth and pharmacy availability vary by state.
Scripx Pharmacy
601 W. FM 544, Suite 102
Murphy, TX 75094
Phone: 469 596 0341
Fax: 469 596 0412
This content is provided for general education and does not replace individualized medical advice. The LDN uses discussed are off label. Compounded medications are not FDA approved.
Frequently Asked Questions
How soon can LDN start working?
There is no established response time that applies to every patient. Clinical studies have evaluated LDN over several weeks, but individual results vary by condition, treatment plan, other medications, and the outcomes being tracked.
Should I feel different immediately after starting LDN?
Not necessarily. An immediate sensation is not required for treatment to be effective, and the absence of an immediate change does not establish whether the medication will eventually help.
Does feeling worse mean LDN is working?
No. Worsening symptoms or side effects are not proof of effectiveness. New, persistent, severe, or worsening symptoms should be reported to the treating provider.
Can I change when I take LDN if it affects my sleep?
Do not change the administration time or dose without guidance from the prescriber or pharmacist. Track the sleep change and discuss it with the clinical team.
How should I track LDN results?
Choose two or three meaningful outcomes, such as pain, sleep, fatigue, symptom flares, or daily function. Record them consistently and review the results during follow up.
Can I use LDN with opioid pain medication?
Naltrexone blocks opioid effects and may precipitate withdrawal in a person with opioid dependence. Current and recent opioid exposure must be reviewed by a qualified clinician before LDN is started.